美国外国出生与美国出生青少年的疫苗接种覆盖率:成就与差距——2012-2014年全国青少年免疫调查
研究利用2012-2014年全国青少年免疫调查数据,比较外国出生与美国出生13-17岁青少年常规推荐疫苗及补种疫苗的接种覆盖率。外国出生青少年乙肝疫苗覆盖率显著低于美国出生青少年(89% vs. 93%),男性HPV疫苗≥3剂覆盖率则较高(22% vs. 14%);调整人口学和社会经济因素后,HPV差异消失而乙肝差异仍存在。两组Tdap、MenACWY、MMR、≥2剂水痘疫苗覆盖率相当,HPV和≥2剂水痘疫苗覆盖率在两组均较低。
要点
- 外国出生青少年乙肝疫苗覆盖率显著低于美国出生青少年(89% vs. 93%)。
- 外国出生男性HPV疫苗≥3剂覆盖率高于美国出生男性(22% vs. 14%),调整后差异消失。
- 两组Tdap、MenACWY、MMR、≥2剂水痘疫苗覆盖率相当,HPV和≥2剂水痘疫苗覆盖率均低。
核心结论
- 外国出生与美国出生青少年在Tdap、MenACWY、MMR和≥2剂水痘疫苗的未调整覆盖率相当。
- 乙肝疫苗覆盖率虽高,但外国出生青少年显著低于美国出生青少年(89% vs. 93%)。
- HPV疫苗和≥2剂水痘疫苗覆盖率在两组中均较低。
研究设计与样本
- 全国青少年免疫调查(NIS-Teen)为随机数字拨号电话调查,对象为13-17岁青少年的照护者,随后对接种提供者进行邮件调查以估计美国青少年人群疫苗接种覆盖率。
- 研究使用2012-2014年NIS-Teen数据,评估常规推荐疫苗和常规儿童期补种疫苗的接种覆盖率,并估计覆盖率患病率和接种率比。
- 共纳入58,090名受访者,其中3.3%为外国出生青少年。
主要发现
- 外国出生与美国出生青少年在保险状态、收入贫困比、教育、访谈语言和家庭规模方面存在显著差异。
- 外国出生青少年乙肝疫苗未调整覆盖率显著低于美国出生青少年(89% vs. 93%)。
- 外国出生男性HPV疫苗≥3剂未调整覆盖率高于美国出生男性(22% vs. 14%)。
- 调整人口学和社会经济因素后,HPV疫苗覆盖率差异消失,但乙肝疫苗覆盖率差异仍存在。
- Tdap、MenACWY、MMR和≥2剂水痘疫苗的未调整覆盖率在两组间相当。
关键数值与推荐
- 常规推荐疫苗:≥1剂Tdap疫苗、≥1剂MenACWY疫苗、≥3剂HPV疫苗。
- 常规儿童期补种疫苗:≥2剂MMR疫苗、≥2剂水痘疫苗、≥3剂乙肝疫苗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An overall increase has been reported in vaccination rates among adolescents during the past decade. Studies of vaccination coverage have shown disparities when comparing foreign-born and U.S.-born populations among children and adults; however, limited information is available concerning potential disparities in adolescents. METHODS: The National Immunization Survey-Teen is a random-digit-dialed telephone survey of caregivers of adolescents aged 13-17 years, followed by a mail survey to vaccination providers that is used to estimate vaccination coverage among the U.S. population of adolescents. Using the National Immunization Survey-Teen data, we assessed vaccination coverage during 2012-2014 among adolescents for routinely recommended vaccines for this age group (≥1 dose tetanus and diphtheria toxoids and acellular pertussis [Tdap] vaccine, ≥1 dose quadrivalent meningococcal conjugate [MenACWY] vaccine, ≥3 doses human papillomavirus [HPV] vaccine) and for routine childhood vaccination catch-up doses (≥2 doses measles, mumps, and rubella [MMR] vaccine, ≥2 doses varicella vaccine, and ≥3 doses hepatitis B [HepB] vaccine). Vaccination coverage prevalence and vaccination prevalence ratios were estimated. RESULTS: Of the 58,090 respondents included, 3.3% were foreign-born adolescents. Significant differences were observed between foreign-born and U.S.-born adolescents for insurance status, income-to-poverty ratio, education, interview language, and household size. Foreign-born adolescents had significantly lower unadjusted vaccination coverage for HepB (89% vs. 93%), and higher coverage for the recommended ≥3 doses of HPV vaccine among males, compared with U.S.-born adolescents (22% vs. 14%). Adjustment for demographic and socioeconomic factors accounted for the disparity in HPV but not HepB vaccination coverage. CONCLUSIONS: We report comparable unadjusted vaccination coverage among foreign-born and U.S.-born adolescents for Tdap, MenACWY, MMR, ≥2 varicella. Although coverage was high for HepB vaccine, it was significantly lower among foreign-born adolescents, compared with U.S.-born adolescents. HPV and ≥2-dose varicella vaccination coverage were low among both groups.
引用
- Healy J, Rodriguez-Lainz A, Elam-Evans LD, et al. Vaccination coverage among foreign-born and U.S.-born adolescents in the United States: Successes and gaps - National Immunization Survey-Teen, 2012-2014. Vaccine. 2018. PMID: 29483032. doi:10.1016/j.vaccine.2018.02.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。